Small-Cap Momentum Watch: Upcoming Catalysts for March 30–April 2

From operational updates to conference participation, we’ve highlighted the small-cap events that could drive attention this week.

--

Companies with Material Events This Week

● INO — Will present at the World Vaccine Congress DC in Washington, DC on March 30, 2026 at 11:50 AM ET, highlighting its DNA-encoded monoclonal antibody technology targeting COVID.

● TIVC — CEO will present at the Emerging Growth Virtual Conference on April 1–2, 2026, including updates on its NIAID-supported preclinical study evaluating Entolimod™ for GI-ARS.

● NWTG — Will present at the Emerging Growth Conference on April 2, 2026 at 10:50 a.m. ET, followed by a live Q&A session.

● DAIC — Will host a live webinar on April 1, 2026 at 1:00 p.m. ET discussing how ambient IoT and AI are transforming asset tracking into operational intelligence.

● KOPN — Will host Demo Days in New York City from April 1–2, 2026, featuring immersive demonstrations across defense, medical, and consumer applications.

● LODE — Will present at the Lytham Partners 2026 Industrials & Basic Materials Investor Summit on April 1, 2026 in a virtual format.

● BESS — Will present at the Emerging Growth Virtual Conference on April 2, 2026 from 1:45–2:15 p.m. ET.

● SND — Will participate in the Lytham Partners 2026 Industrials & Basic Materials Investor Summit on April 1, 2026 via webcast.

● PDC — CEO will present at the Emerging Growth Conference on April 1, 2026 at 12:35 p.m. ET and host investor Q&A.

● IGC — Will showcase its AI platform at the AD/PD 2026 Conference from April 1–5, 2026.

● GPMT — Declared a quarterly dividend payable April 15, 2026, to shareholders of record as of April 1, 2026.

● LFS — Entered a partnership to launch a new soccer school in Japan beginning April 1, 2026, expanding its presence to 46 of 47 prefectures.

● SES — Will participate in Drones and Uncrewed Asia from March 31–April 1, 2026 in Singapore.

● REVB — Will present clinical data at the Advances in Critical Care Nephrology conference from March 29–April 1, 2026 in San Diego.

● TLPH — Will present two abstracts at the AKI & CRRT 2026 conference from March 29–April 2, 2026 in San Diego.

● AKBA — Will host a virtual R&D Day on April 2, 2026 at 10:00 AM ET, highlighting its pipeline across multiple kidney disease programs.

● MIGI — Will present at the Emerging Growth Conference on April 2, 2026 from 2:55–3:05 p.m. ET.

● CETY — Will exhibit at the International Biomass Conference & Expo from March 31–April 2, 2026 in Nashville, showcasing its waste-to-energy technology.

● SXTP — Partnership with Runway Health to expand access to ARAKODA® launches April 2, 2026, enhancing travel medicine distribution.

● MIST — Will present at ACC.26 in New Orleans (March 28–30, 2026), including an Expert Theater session on March 30, 2026 from 12:00–1:00 p.m. CT.

● LGVN — Scheduled for an FDA Type C meeting at the end of March 2026 to align on endpoints and statistical analysis for a potential BLA.

● AGEN — Will host a stakeholder webcast on March 31, 2026 at 4:30 p.m. ET providing updates on its BOT+BAL program and 2026 priorities.

● RVYL — At its Special Meeting of Shareholders regarding the planned merger with RTB Digital, 99% of votes cast continue to support the transaction, with the meeting further adjourned to allow additional vote collection. The meeting will reconvene virtually on April 1, 2026 at 4:00 p.m. EST.

● OSTX — Remains on track to deliver to the FDA the clinical and biomarker data requested in preparation for its upcoming Type B Pre-BLA Meeting by the end of the first quarter of 2026.

● MAMO — Entered a non-binding LOI to acquire 100% of FST Development Company Limited, a technology company focused on intelligent hardware and AI-driven system-level solutions. The LOI includes a 60-day exclusivity period, and the parties intend to execute final agreements by late March 2026, subject to due diligence, board approvals, and regulatory conditions.

--

Disclaimer: All content provided by BigTimePennys Report is for informational purposes only. The information provided should not be considered as a substitute for professional advice, analysis, or guidance. Any investment decisions made based on the information provided are solely at the user's own risk. BigTimePennys Report are not liable for any losses or damages incurred as a result of using this information. BigTimePenny is not operated by a licensed broker, a dealer, or a registered investment adviser. The Securities Litigation Reform Act of 1995 provides safe harbor protection for forward-looking statements made by companies or individuals. It should be noted that any forward-looking statements made by BigTimePennys Report, its authors, are not guarantees of future performance or results. These statements are subject to risks, uncertainties, and assumptions that may cause actual results to differ materially from those expressed or implied in the forward-looking statements. The content provided by BigTimePennys Report does not constitute an endorsement, recommendation, or solicitation to buy, sell, or hold any securities or investment products. BigTimePennys Report, its authors, do not endorse or recommend any specific investment strategies, securities, or companies. It is crucial to conduct thorough research and seek advice from a qualified professional before making any investment decisions. Nothing in this article constitutes professional and/or financial advice, nor does any information in the article constitute a comprehensive or complete statement of the matters discussed or the law relating thereto. The user assumes full responsibility for the use of the information provided by BigTimePennys Report. BigTimePennys Report, its authors, disclaim any liability for any direct, indirect, or consequential damages arising from the use or reliance on the information provided. Users should exercise their own judgment and discretion when interpreting and utilizing the information provided. Please note that the content provided by BigTimePennys Report is based on available information and sources believed to be reliable. However, market conditions and regulations may change over time, and there may be inaccuracies or errors in the information provided. It is recommended to verify the information with current and reliable sources before making any investment decisions. Investing in micro-cap companies is highly speculative and carries an extremely high degree of risk. BigTimePenny is not a fiduciary by virtue of any person's use of or access to this content. We were NOT compensated for this article.